Name
PEREARST GULJAJEVA OÜ
Registry code
11418872
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
03.09.2007 (17)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
277 506 €
75 211 €
27%
2 912 €
(estimate is approximate)
90 400 €
2
Submitted
No tax arrears
83%
68%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Svetlana Guljajeva 05.04.1959 (65) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| Varvara Guljajeva 10.08.1984 (40) | 100% - 2 556.00 EUR | Board member | - | |
| Ilmar Kerge 05.03.1983 (41) | 100% - 2 556.00 EUR | - | - |
| 2019 25.03.2020 | 2020 14.04.2021 | 2021 14.03.2022 | 2022 17.04.2023 | 2023 12.02.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 165 240 € | 161 433 € | 184 840 € | 217 386 € | 277 506 € |
| Net profit (loss) for the period | 23 695 € | 31 331 € | 44 049 € | 39 726 € | 75 211 € |
| Profit Margin | 14% | 19% | 24% | 18% | 27% |
| Current Assets | 40 962 € | 54 266 € | 47 791 € | 50 768 € | 83 075 € |
| Fixed Assets | 1 131 € | 830 € | 4 156 € | 32 877 € | 27 440 € |
| Total Assets | 42 093 € | 55 096 € | 51 947 € | 83 645 € | 110 515 € |
| Current Liabilities | 11 515 € | 13 186 € | 14 484 € | 22 456 € | 20 115 € |
| Non Current Liabilities | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 30 578 € | 41 910 € | 37 463 € | 61 189 € | 90 400 € |
| Employees | 3 | 3 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 16 169.72 € | 11 261.9 € | 2 |
| 2023 Q4 | - | 8 198.48 € | 8 670.88 € | 2 |
| 2023 Q3 | - | 15 041.75 € | 10 123.09 € | 2 |
| 2023 Q2 | - | 15 047.95 € | 11 614.74 € | 2 |
| 2023 Q1 | - | 9 645.89 € | 10 244.78 € | 2 |
| 2022 Q4 | - | 8 819.64 € | 9 375.84 € | 2 |
| 2022 Q3 | - | 8 819.64 € | 9 375.84 € | 2 |
| 2022 Q2 | - | 12 824.64 € | 10 580.14 € | 2 |
| 2022 Q1 | - | 9 171.83 € | 9 739.97 € | 2 |
| 2021 Q4 | - | 9 675.27 € | 7 611.14 € | 2 |
| 2021 Q3 | - | 6 805.74 € | 7 224.78 € | 2 |
| 2021 Q2 | - | 15 632.71 € | 8 299.71 € | 2 |
| 2021 Q1 | - | 7 304.88 € | 7 755.77 € | 2 |
| 2020 Q4 | - | 7 769.58 € | 8 271.83 € | 3 |
| 2020 Q3 | - | 6 897.66 € | 7 334.54 € | 4 |
| 2020 Q2 | - | 11 647.84 € | 8 070.59 € | 3 |
| 2020 Q1 | - | 7 193.83 € | 7 644.22 € | 3 |
